Author Maureen M. Kelly, MS, RN, CPNP Clinical Assistant Professor, School of Nursing Pediatric Nurse Practitioner, Division of Pediatric Gastroenterology University of North Carolina at Chapel Hill Chapel Hill, NC
0.5 NAPNAP CE contact hours
The challenges associated with the diagnosis and differentiation of pediatric IBD are numerous and include varying clinical presentations and appropriate diagnostic modalities. Treatment is often impeded by a lack of clinical trial data on which to develop guidelines, as well as a lack of consideration of pediatric-specific issues. Likewise, there are myriad management issues surrounding pediatric IBD that, if not handled in an appropriate and timely fashion, can result in poorer physical and psychosocial outcomes. This activity outlines the diagnosis and management of IBD in an effort to enhance the ability of pediatric nurse practitioners to best care for their patients.
This activity is jointly provided by the National Association of Pediatric Nurse Practitioners and MCM Education.
This activity is designed for pediatric nurse practitioners and other clinicians with an interest in this topic.
Upon completion of this educational activity, the participant should be able to:
Discuss clinical, laboratory, and imaging findings indicative of IBD in pediatric patients.
Identify appropriate pharmacologic treatment of pediatric IBD based on underlying pathophysiology and symptomology.
It is the policy of the National Association of Pediatric Nurse Practitioners to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Ms. Kelly discloses that she has served as a consultant for AbbVie. Credit Statements
This program is accredited for 0.5 NAPNAP CE contact hours per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.
Commercial Support Statements
Supported by an independent educational grant from AbbVie.
Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
Please turn off all pop-up blockers to allow access to the educational activity.
Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 30 minutes to complete.
After you have finished reviewing the activity, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
©2014, MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Pediatric Nurse Practitioners, or AbbVie. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.